Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Colin Louis Masters Insider Profile
4 Followers
Colin Louis Masters, Director at Alterity Therapeutics Ltd., holds 184.67K shares in Alterity Therapeutics Ltd. (Ticker: PRNAF). Most recently, Colin Louis Masters ― shares of Alterity Therapeutics Ltd. on ― for an estimated value of ―.
Colin Louis Masters has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Colin Louis Masters's holdings
Insider Roles
Director
Roles that Colin Louis Masters holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Colin Louis Masters
Colin Louis Masters's Trading History
List of latest transactions for each holding click on a transaction to see Colin Louis Masters's performance on stock
You May Also Like
Colin Louis Masters insider profile FAQ
What is the percentage of profitable transactions made by Colin Louis Masters?
The percentage of profitable transactions made by Colin Louis Masters is ―.
What is the average return per transaction made by Colin Louis Masters?
The average return per transaction made by Colin Louis Masters is ―.
What stocks does Colin Louis Masters hold?
Colin Louis Masters holds: PRNAF stocks.
What was Colin Louis Masters’s latest transaction?
Colin Louis Masters latest transaction was an Uninformative Buy of ―.
What was Colin Louis Masters's most profitable transaction?
Colin Louis Masters’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Colin Louis Masters's role in Alterity Therapeutics Ltd.?
Colin Louis Masters's role in Alterity Therapeutics Ltd. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.